by Elena Iemma | Oct 20, 2022 | Featured, Thinking Out Loud -Blog
The Epi-Team takes over PharmSci360 in Boston! That’s right! The Epi-Team was out in force at the annual AAPS PharmSci 360 meeting this week in the beautiful and historic city of Boston. Special thanks to Amy Rosenberg for moderating the discussion at my talk...
by Elena Iemma | Oct 17, 2022 | Events, Featured
We had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below! Talks: Anne De Groot, M.D., EpiVax, Inc. Deimmunization and...
by Elena Iemma | Sep 22, 2022 | Featured, Thinking Out Loud -Blog
FDA Awards $2M in Funding to EpiVax Host Cell Protein Study Remember when the CHO genome sequence came out? Ok, so you don’t, but we do! We built an app for that (see our paper entitled “Of [Hamsters] and Men”) and so, we will now perform validating...
by Elena Iemma | Sep 12, 2022 | Featured, News
PROVIDENCE, RI, September 12, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk...
by Elena Iemma | Aug 22, 2022 | Featured, Thinking Out Loud -Blog
After almost three year of virtual meetings, EpiVax is back on the road in earnest this fall! We are so excited to reconnect in person with our clients, partners and friends around the globe. And this fall we have an ambitious travel schedule! Check out the list...